EUVIMEDEUVIMED entdecken
Open Access

Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase

Ruipeng Lei, Wooseob Kim, Huibin Lv, Zongjun Mou, Michael J Scherm, Aaron J Schmitz, Jackson S Turner, Timothy J C Tan, Yiquan Wang, Wenhao O Ouyang, Weiwen Liang, Joel Rivera-Cardona und 9 weitere

Immunity · 2023-11 · 56 (11) · 2621-2634.e6

DOI: 10.1016/j.immuni.2023.10.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2023-11. Verfasst von Ruipeng Lei und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines, Orthomyxoviridae Infections, Influenza A Virus, H1N1 Subtype. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCCIH NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is growing appreciation for neuraminidase (NA) as an influenza vaccine target; however, its antigenicity remains poorly characterized. In this study, we isolated three broadly reactive N2 antibodies from the plasmablasts of a single vaccinee, including one that cross-reacts with NAs from seasonal H3N2 strains spanning five decades. Although these three antibodies have diverse germline usages, they recognize similar epitopes that are distant from the NA active site and instead involve the highly conserved underside of NA head domain. We also showed that all three antibodies confer prophylactic and therapeutic protection in vivo, due to both Fc effector functions and NA inhibition through steric hindrance. Additionally, the contribution of Fc effector functions to protection in vivo inversely correlates with viral growth inhibition activity in vitro. Overall, our findings advance the understanding of NA antibody response and provide important insights into the development of a broadly protective influenza vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanInfluenza VaccinesOrthomyxoviridae InfectionsInfluenza A Virus, H1N1 SubtypeHumansNeuraminidaseInfluenza A Virus, H3N2 SubtypeEpitopesAntibodies, ViralAntibodies, MonoclonalVaccinationHemagglutinin Glycoproteins, Influenza Virus

Stichwörter der Autor:innen

antibodycross-reactivecryo-EMinfluenza virusneuraminidaseprotectivestructuresvaccination

Substanzen

Influenza VaccinesNeuraminidaseEpitopesAntibodies, ViralAntibodies, MonoclonalHemagglutinin Glycoproteins, Influenza Virus

Autor:innen und Institutionen

  • Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
  • Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA; Department of Microbiology, Korea University College of Medicine, Seoul 02841, Korea.
  • Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA; HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong…
  • Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.

Förderung

  • NIAID NIH HHS
  • NCCIH NIH HHS
  • National Institutes of Health
  • NIAID
  • Kinship Foundation
  • Michelson Prize and Grants
  • National Research Foundation of Korea
  • Pasteur Institute

Zitieren

APA

Lei, R., Kim, W., Lv, H., Mou, Z., Scherm, M. J., Schmitz, A. J., Turner, J. S., Tan, T. J. C., Wang, Y., Ouyang, W. O., Liang, W., Rivera-Cardona, J., Teo, C., Graham, C. S., Brooke, C. B., Presti, R. M., Mok, C. K. P., Krammer, F., Dai, X., …, & Wu, N. C. (2023). Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase. Immunity, 56(11), 2621-2634.e6. https://doi.org/10.1016/j.immuni.2023.10.005

Vancouver

Lei R, Kim W, Lv H, Mou Z, Scherm MJ, Schmitz AJ, et al. Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase. Immunity. 2023;56(11):2621-2634.e6. doi:10.1016/j.immuni.2023.10.005

BibTeX
@article{Lei2023,
  author = {Lei, Ruipeng and Kim, Wooseob and Lv, Huibin and Mou, Zongjun and Scherm, Michael J and Schmitz, Aaron J and Turner, Jackson S and Tan, Timothy J C and Wang, Yiquan and Ouyang, Wenhao O and Liang, Weiwen and Rivera-Cardona, Joel and Teo, Chuyun and Graham, Claire S and Brooke, Christopher B and Presti, Rachel M and Mok, Chris K P and Krammer, Florian and Dai, Xinghong and Ellebedy, Ali H and Wu, Nicholas C},
  title = {Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase},
  journal = {Immunity},
  year = {2023},
  volume = {56},
  number = {11},
  pages = {2621--2634.e6},
  doi = {10.1016/j.immuni.2023.10.005}
}
Kostenlos starten →